4Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency[J]. Am J Med, 1984,76 :47- 56.
5Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality [ J ].Arthritis Rheum, 1986,29:82 - 87.
6Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin[J]. Br J Dermatol, 1956, 68(11): 355-361.
7Melish ME, Glasgow LA. The staphylococcal scalded-skin syndrome.[J]. N Engl J Med, 1970, 282(20): 1114-1119.
8Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme[J]. Arch Dermatol, 1993, 129(1): 92-96.
9Kelly JP, Auquier A, Rzany B, et al. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR).Design and methods[J]. J Clin Epidemiol, 1995, 48(9): 1099-1108.
10Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis[J]. N Engl J Med, 1995, 333(24): 1600-1607.
